# New Leaf Venture Partners: portfolio, investments and team

> New Leaf Venture Partners is a vc firm based in United States. 110 investments on record, 1 in the last 12 months, latest Oct 2026.

Source: https://millionrounds.com/fund/new-leaf-venture-partners (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# New Leaf Venture Partners

Last cheque observed Oct 2026; 110 cheques on record.

Deploying now VC firm

Seed Series A Series B Well-being E-health Healthcare

Deploying now

**100%** of best year **1** **cheques in 12 months**, 110 on record

Since the last cheque **4** days **00** hrs **00** min **00** sec

Median round **$55M** Rounds led **0 of 110** Sole investor **3 rounds** Exits **10 from the portfolio** Mostly in **United States, 98%**

Pitch New Leaf Venture Partners

## New Leaf Venture Partners highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series B and Venture: 50% of its rounds
- 03 Sole investor in 3 rounds, median $27M
- 04 10 exits from the portfolio

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth Pre-IPO
- **Sectors:** Well-being E-health Healthcare
- **Based in:** New York, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **110 appearances**

- **2026** 1 round
- **Oct** **[Star Therapeutics](https://millionrounds.com/company/star-therapeutics)** US · Pulse 2.0 **$200M** With 10 others
- **2019** 3 rounds
- **Nov** **[AiCure](https://millionrounds.com/company/aicure)** Series C · US · FinSMEs **$25M** With 10 others
- **Sept** **[Passage Bio](https://millionrounds.com/company/passage-bio)** Series B · US · Endpts **$110M** With 6 others
- **Aug** **[Renovacor](https://millionrounds.com/company/renovacor)** Series A · US · FinSMEs **$11M** With 4 others
- **2018** 1 round
- **Aug** **[ReViral](https://millionrounds.com/company/reviral)** Series B · GB · FinSMEs **$55M** With 2 others
- **2015** 13 rounds
- **Dec** **[True North Therapeutics](https://millionrounds.com/company/true-north-therapeutics)** Series C · US **$40M** With 5 others
- **Oct** **[Arvinas](https://millionrounds.com/company/arvinas)** Series B · US **$41M** With 4 others
- **Sept** **[Deciphera Pharmaceuticals](https://millionrounds.com/company/deciphera-pharmaceuticals)** Series B · US **$75M** Sole investor
- **Sept** **[Kyruus](https://millionrounds.com/company/kyruus)** Series C · US **$25M** With 7 others
- **Aug** **[ReShape Medical](https://millionrounds.com/company/reshape-medical)** Series D · US **$38M** With 5 others
- **Aug** **[Wave Life Sciences](https://millionrounds.com/company/wave-life-sciences)** Series B · US **$66M** With 6 others
- **Jul** **[Afferent Pharmaceuticals](https://millionrounds.com/company/afferent-pharmaceuticals)** Series C · US **$55M** With 5 others
- **Jun** **[Advanced Cell Diagnostics](https://millionrounds.com/company/advanced-cell-diagnostics)** Series C · US **$22M** With 3 others
- **Jun** **[UNUM Therapeutics](https://millionrounds.com/company/unum-therapeutics)** Series B · US **$65M** With 11 others
- **Apr** **[Neuronetics](https://millionrounds.com/company/neuronetics)** Series F · US **$34M** With 7 others
- **Apr** **[Dimension Therapeutics](https://millionrounds.com/company/dimension-therapeutics)** Series B · US **$65M** With 7 others
- **Apr** **[Edge Therapeutics](https://millionrounds.com/company/edge-therapeutics)** Series C · US **$56M** With 5 others
- **Jan** **[Kit Check](https://millionrounds.com/company/kit-check)** Series B · US **$12M** With 5 others
- **2014** 6 rounds
- **Dec** **[CardioKinetix](https://millionrounds.com/company/cardiokinetix)** Series F · US **$50M** With 4 others
- **May** **[QPID Health](https://millionrounds.com/company/qpid-health)** Series B · US **$12M** With 1 other
- **Apr** **[Principia BioPharma](https://millionrounds.com/company/principia-biopharma)** Series B · US **$50M** With 5 others
- **Apr** **[Intarcia Therapeutics](https://millionrounds.com/company/intarcia-therapeutics)** Growth · US **$200M** With 5 others
- **Feb** **[Versartis](https://millionrounds.com/company/versartis)** Series E · US **$55M** With 3 others
- **Jan** **[TigerText](https://millionrounds.com/company/tigertext)** Series B · US **$21M** With 6 others
- **2013** 9 rounds
- **Oct** **[Versartis](https://millionrounds.com/company/versartis)** Series D · US · finsmes.com **$20M** With 5 others
- **Jul** **[Karyopharm Therapeutics](https://millionrounds.com/company/karyopharm-therapeutics)** Series B · US · pevc.dowjones.com **$19M** With 2 others
- **Jul** **[Versartis](https://millionrounds.com/company/versartis)** Series C · US · sec.gov **$12M** With 3 others
- **Jun** **[Kit Check](https://millionrounds.com/company/kit-check)** Series A · US · techcrunch.com **$10M** With 4 others
- **Apr** **[iRhythm Technologies](https://millionrounds.com/company/irhythm-technologies)** Series D · US · finsmes.com **$16M** With 4 others
- **Apr** **[Pearl Therapeutics](https://millionrounds.com/company/pearl-therapeutics)** Growth · US **$42M** With 3 others
- **Mar** **[CardioKinetix](https://millionrounds.com/company/cardiokinetix)** Series E · US · finsmes.com **$23M** With 4 others
- **Feb** **[Aviir](https://millionrounds.com/company/aviir)** Series B · US · finsmes.com **$10M** With 3 others
- **Jan** **[Versartis](https://millionrounds.com/company/versartis)** Series C · US · fiercebiotech.com **$25M** With 3 others
- **2012** 20 rounds
- **Nov** **[Intarcia Therapeutics](https://millionrounds.com/company/intarcia-therapeutics)** Debt · US · intarcia.com **$50M** With 2 others
- **Nov** **[Pearl Therapeutics](https://millionrounds.com/company/pearl-therapeutics)** Series D · US · finsmes.com **$65M** With 3 others
- **Nov** **[Advanced Cell Diagnostics](https://millionrounds.com/company/advanced-cell-diagnostics)** Series B · US · finance.yahoo.com **$12M** With 1 other
- **Oct** **[Principia BioPharma](https://millionrounds.com/company/principia-biopharma)** Series A · US · bizjournals.com **$13M** With 4 others
- **Oct** **[ReShape Medical](https://millionrounds.com/company/reshape-medical)** Series C · US · pevc.dowjones.com **$15M** With 2 others
- **Oct** **[Pearl Therapeutics](https://millionrounds.com/company/pearl-therapeutics)** Growth · US **$23M** With 3 others
- **Oct** **[Relypsa](https://millionrounds.com/company/relypsa)** Venture · US **$2.6M** With 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **3 named**

CL **Craig Lawrence Slutzkin** Chief Operating Officer, Chief Financial Officer, Chief Compliance Officer i Form ADV

RM **Ronald Martin Hunt** Managing Director i Form ADV

VK **Vijay Kiran Lathi** Managing Director i Form ADV

We also hold **11** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

## What the register says

From the firm's own filings with the SEC, which it must file accurately by law

**$408M** assets it manages Oct 2026

**Registered** investment adviser full reporting to the SEC

- **Legal name:** NEW LEAF Venture Partners LLC
- **SEC number:** CRD 163897

Funds on its Form ADV

**9** private funds, **$654M** in gross assets · filed Mar 2024

- New Leaf Ventures III, L.P. *Venture* 34 investors $179M
- New Leaf Ventures IV, L.P. *Venture* 15 investors $160M
- New Leaf Biopharma Opportunities II, L.P. *Venture* 9 investors $130M
- NLV-II SPV-2, L.P. *Venture* 2 investors $79M
- NLV-II SPV-1, L.P. *Venture* 14 investors $78M
- New Leaf Biopharma Opportunities I, L.P. *Venture* 2 investors $10.0M
- NLV Co-Invest III, LLC *Venture* 1 investor $9.1M
- NLV Co-Invest II, LLC *Venture* 3 investors $5.3M
- New Leaf Ventures I, L.P. *Venture* 46 investors $3.9M

## Exits from the portfolio

Companies it backed that were later bought or listed **10 in all**

**[Synageva BioPharma](https://millionrounds.com/company/synageva-biopharma)** Bought by [Alexion Pharmaceuticals](https://millionrounds.com/fund/alexion-pharmaceuticals) **$8.4B** May 2015

**[Convergence Pharmaceuticals](https://millionrounds.com/company/convergence-pharmaceuticals)** Bought by [Biogen Idec](https://millionrounds.com/fund/biogen-idec) **$675M** Jan 2015

**[Access Closure](https://millionrounds.com/company/access-closure)** Bought by [Cardinal Health](https://millionrounds.com/fund/cardinal-health) **$320M** Apr 2014

**[Stromedix](https://millionrounds.com/company/stromedix)** Bought by [Biogen Idec](https://millionrounds.com/fund/biogen-idec) **$750M** Feb 2014

**[Oxford Immunotec](https://millionrounds.com/company/oxford-immunotec)** Listed **$64M** Nov 2013

**[Karyopharm Therapeutics](https://millionrounds.com/company/karyopharm-therapeutics)** Listed **Undisclosed** Nov 2013

**[Pearl Therapeutics](https://millionrounds.com/company/pearl-therapeutics)** Bought by [AstraZeneca](https://millionrounds.com/fund/astrazeneca) **$1.1B** Jun 2013

**[Artisan Pharma](https://millionrounds.com/company/artisan-pharma)** Bought by Asahi Kasei Pharma **Undisclosed** Nov 2011

**[Interlace Medical](https://millionrounds.com/company/interlace-medical)** Bought by Hologic **$125M** Jan 2011

**[Visiogen](https://millionrounds.com/company/visiogen)** Bought by [Abbott Labs](https://millionrounds.com/fund/abbott-labs) **$400M** Sept 2009

An exit counts when it came after the firm's first round in the company. From historical deal records.

## The cheque

Seed Series A Series B

Median round joined **$55M** the round, not its cheque Alone, median **$27M**

Led 0 of 110 rounds **0%**

- **Sole investor:** 3 rounds
- **Last cheque:** Oct 2026
- **Exits:** 10 from the portfolio

Rounds by stage said on their site

- Series B said *28*
- Venture *21*
- Series C *19*
- Series A said *15*
- Series D *10*
- Growth said *5*
- Seed said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [5AM Ventures](https://millionrounds.com/fund/5am-ventures) 12
- [OrbiMed](https://millionrounds.com/fund/orbimed) 12
- [SV Life Sciences](https://millionrounds.com/fund/sv-life-sciences) 10
- [Three Arch Partners](https://millionrounds.com/fund/three-arch-partners) 9
- [Aberdare Ventures](https://millionrounds.com/fund/aberdare-ventures) 8
- [Bay City Capital](https://millionrounds.com/fund/bay-city-capital) 8

**Pitching New Leaf Venture Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as New Leaf Venture Partners. A count of rooms they were both in, not a relationship either has claimed.

[**5AM Ventures** VC firm **12** rounds together](https://millionrounds.com/fund/5am-ventures)[**OrbiMed** Private equity **12** rounds together](https://millionrounds.com/fund/orbimed)[**SV Life Sciences** VC firm **10** rounds together](https://millionrounds.com/fund/sv-life-sciences)[**Three Arch Partners** Growth equity **9** rounds together](https://millionrounds.com/fund/three-arch-partners)[**Aberdare Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/aberdare-ventures)[**Bay City Capital** VC firm **8** rounds together](https://millionrounds.com/fund/bay-city-capital)[**Clarus Ventures** VC firm **8** rounds together](https://millionrounds.com/fund/blackstone)[**Venrock** VC firm **7** rounds together](https://millionrounds.com/fund/venrock)[**Canaan** VC firm **6** rounds together](https://millionrounds.com/fund/canaan-partners)[**New Enterprise Associates** VC firm **6** rounds together](https://millionrounds.com/fund/new-enterprise-associates)[**Aisling Capital** Private equity **5** rounds together](https://millionrounds.com/fund/aisling-capital)[**Foundation Medical Partners** Private equity **5** rounds together](https://millionrounds.com/fund/foundation-medical-partners)

## Recently backed

The latest companies New Leaf Venture Partners put money into.

[**Star Therapeutics** $200M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**AiCure** $25M · Nov 2019](https://millionrounds.com/company/aicure)[**ReViral** $55M · Aug 2018](https://millionrounds.com/company/reviral)

## Quick answers about New Leaf Venture Partners

### What does New Leaf Venture Partners invest in?

New Leaf Venture Partners invests most often at Series B and Venture (50% of the rounds on record), in sectors such as Well-being, E-health and Healthcare.

### How active is New Leaf Venture Partners?

110 investments on record, 1 of them in the last 12 months. The most recent was in Oct 2026.

### What has New Leaf Venture Partners invested in recently?

Its most recent investments on record: Star Therapeutics (Undisclosed round, Oct 2026), AiCure (Series C, Nov 2019) and Passage Bio (Series B, Sept 2019).

### How big are New Leaf Venture Partners's cheques?

The median round it joins is $55M.

### Does New Leaf Venture Partners lead rounds?

Rarely, if at all: none of its 110 investments on record names it as the lead.

### Where does New Leaf Venture Partners invest?

Most of the companies it backs are in the United States (98%).

### Is New Leaf Venture Partners investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does New Leaf Venture Partners invest alongside?

Most often 5AM Ventures (12 rounds together), OrbiMed (12 rounds together) and SV Life Sciences (10 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=new-leaf-venture-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=new-leaf-venture-partners)